We hypothesized that alterations in the expression levels of several epigenetic regulators, such as MeCP2, DNMT1, HDAC1, H3Ac and H4Ac, are responsible for the loss of claudin-6 in breast invasive ductal carcinomas. This evidence concerns the gene CLDN6 and medical procedure.